Patents Assigned to INTRABIO LIMITED
  • Therapeutic agents for neurodegenerative diseases
    Patent number: 11793782
    Abstract: The present disclosure provides for treating neurodegenerative diseases comprising administering leucine, acetyl-leucine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: October 24, 2023
    Assignee: IntraBio Limited
    Inventor: Mallory Factor
  • Therapeutic agents for treating restless leg syndrome
    Patent number: 11660279
    Abstract: The present disclosure provides for treatments of restless legs syndrome (RLS) or one or more symptoms associated with RLS comprising administering leucine, acetyl-leucine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: May 30, 2023
    Assignee: INTRABIO LIMITED
    Inventors: Mallory Factor, Michael Strupp
  • Pharmaceutical compositions and uses directed to lysosomal storage disorders
    Patent number: 11400067
    Abstract: The present disclosure provides for treating lysosomal storage disorders (LSDs) comprising administering acetyl-leucine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: August 2, 2022
    Assignee: INTRABIO LIMITED
    Inventor: Michael Strupp
  • THERAEUTIC AGENTS FOR NEURODEGENERATIVE DISEASES
    Publication number: 20210196659
    Abstract: The present disclosure provides for treating neurodegenerative diseases comprising administering leucine, acetyl-leucine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 15, 2018
    Publication date: July 1, 2021
    Applicant: INTRABIO LIMITED
    Inventor: Mallory FACTOR